Peptide-lipid conjugates, liposomes and liposomal drug delivery
CA 2376859 A1 · Owner: Ahl, Patrick · Inventors: Franklin, J. Craig; Cabral-Lilly, Donna; Ahl, Patrick
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells and hence, to deliver the liposomes to the vicinity of the target cells or , directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g. tumors microbial infection and , inflammations characterized by the occurrence of peptidase-secreting cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 13, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 13, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.